{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:02:11Z","timestamp":1782309731964,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hospital Infection"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.jhin.2012.12.019","type":"journal-article","created":{"date-parts":[[2013,7,19]],"date-time":"2013-07-19T20:30:30Z","timestamp":1374265830000},"page":"22-27","source":"Crossref","is-referenced-by-count":22,"title":["Comparison of treatment outcomes with vancomycin alone versus combination therapy in severe Clostridium difficile infection"],"prefix":"10.1016","volume":"85","author":[{"given":"S.N.","family":"Bass","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.R.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.A.","family":"Neuner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.W.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhin.2012.12.019_bib1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/502539","article-title":"A\u00a0large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use","volume":"26","author":"Muto","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jhin.2012.12.019_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1503\/cmaj.1031189","article-title":"Clostridium difficile-associated diarrhea in adults","volume":"171","author":"Poutanen","year":"2004","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.jhin.2012.12.019_bib3","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa051639","article-title":"A\u00a0predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality","volume":"353","author":"Loo","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhin.2012.12.019_bib4","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa051590","article-title":"An epidemic, toxin gene-variant strain of Clostridium difficile","volume":"353","author":"McDonald","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhin.2012.12.019_bib5","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1086\/430315","article-title":"Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada","volume":"40","author":"Pepin","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2012.12.019_bib6","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3201\/eid1309.061116","article-title":"Increase in Clostridium difficile-related mortality rates, United States, 1999\u20132004","volume":"13","author":"Redelings","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jhin.2012.12.019_bib7","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s11908-012-0298-9","article-title":"Clostridium difficile: changing epidemiology, treatment and infection prevention measures","volume":"14","author":"Cecil","year":"2012","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.jhin.2012.12.019_bib8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)","volume":"31","author":"Cohen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jhin.2012.12.019_bib9","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1128\/AAC.46.6.1647-1650.2002","article-title":"Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin","volume":"46","author":"Pelaez","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhin.2012.12.019_bib10","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/gut.27.10.1169","article-title":"Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile","volume":"27","author":"Bolton","year":"1986","journal-title":"Gut"},{"key":"10.1016\/j.jhin.2012.12.019_bib11","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/bmj.2.6153.1667","article-title":"Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea","volume":"2","author":"Keighley","year":"1978","journal-title":"Br Med J"},{"key":"10.1016\/j.jhin.2012.12.019_bib12","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1469-0691.2009.03099.x","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI)","volume":"15","author":"Bauer","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2012.12.019_bib13","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1345\/aph.1Q080","article-title":"Tigecycline for the treatment of severe Clostridium difficile infection","volume":"45","author":"Larson","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jhin.2012.12.019_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1592\/phco.26.3.299","article-title":"Clostridium difficile-associated disease: an emerging threat to patient safety: insights from the Society of Infectious Diseases Pharmacists","volume":"26","author":"Owens","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jhin.2012.12.019_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11606-006-0008-0","article-title":"Predicting Clostridium difficile stool cytotoxin results in hospitalized patients with diarrhea","volume":"12","author":"Katz","year":"1997","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jhin.2012.12.019_bib16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J\u00a0Chronic Dis"},{"key":"10.1016\/j.jhin.2012.12.019_bib17","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1001\/jama.286.14.1754","article-title":"Serial evaluation of the SOFA score to predict outcome in critically ill patients","volume":"286","author":"Ferreira","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jhin.2012.12.019_bib18","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1086\/596552","article-title":"Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study","volume":"48","author":"Musher","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2012.12.019_bib19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1086\/506354","article-title":"Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of Clostridium difficile-associated diarrhea","volume":"43","author":"Lagrotteria","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2012.12.019_bib20","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/jac\/dkp048","article-title":"In\u00a0vitro effect of metronidazole and vancomycin in combination on Clostridium difficile","volume":"63","author":"Hames","year":"2009","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jhin.2012.12.019_bib21","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0140-6736(83)91036-X","article-title":"Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis","volume":"2","author":"Teasley","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.jhin.2012.12.019_bib22","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/519265","article-title":"A\u00a0comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity","volume":"45","author":"Zar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2012.12.019_bib23","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","article-title":"Fidaxomicin versus vancomycin for Clostridium difficile infection","volume":"364","author":"Louie","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhin.2012.12.019_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0195-6701(98)90019-6","article-title":"Risk factors for Clostridium difficile infection","volume":"40","author":"Bignardi","year":"1998","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.jhin.2012.12.019_bib25","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1128\/AAC.05647-11","article-title":"Prospective observational study comparing three different treatment regimes in patients with Clostridium difficile infection","volume":"56","author":"Wenisch","year":"2012","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Hospital Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670113002235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670113002235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T12:54:00Z","timestamp":1539521640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195670113002235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0195670113002235"],"URL":"https:\/\/doi.org\/10.1016\/j.jhin.2012.12.019","relation":{},"ISSN":["0195-6701"],"issn-type":[{"value":"0195-6701","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}